These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 25403466)

  • 21. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells.
    Awaya T; Kato T; Mizuno Y; Chang H; Niwa A; Umeda K; Nakahata T; Heike T
    PLoS One; 2012; 7(12):e51638. PubMed ID: 23236522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
    Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
    Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors.
    Darabi R; Santos FN; Filareto A; Pan W; Koene R; Rudnicki MA; Kyba M; Perlingeiro RC
    Stem Cells; 2011 May; 29(5):777-90. PubMed ID: 21374762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic human ES and iPS reporter cell lines for identification and selection of pluripotent stem cells in vitro.
    Ovchinnikov DA; Titmarsh DM; Fortuna PR; Hidalgo A; Alharbi S; Whitworth DJ; Cooper-White JJ; Wolvetang EJ
    Stem Cell Res; 2014 Sep; 13(2):251-61. PubMed ID: 25108530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture.
    Jiwlawat S; Lynch E; Glaser J; Smit-Oistad I; Jeffrey J; Van Dyke JM; Suzuki M
    Differentiation; 2017; 96():70-81. PubMed ID: 28915407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 4 Moderately Affects Competence of Pluripotent Stem Cells for Myogenic Conversion.
    Świerczek-Lasek B; Neska J; Kominek A; Tolak Ł; Czajkowski T; Jańczyk-Ilach K; Stremińska W; Piwocka K; Ciemerych MA; Archacka K
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
    Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
    Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-directed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells.
    Wu DT; Seita Y; Zhang X; Lu CW; Roth MJ
    PLoS One; 2012; 7(4):e34778. PubMed ID: 22536330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells.
    Maffioletti SM; Gerli MF; Ragazzi M; Dastidar S; Benedetti S; Loperfido M; VandenDriessche T; Chuah MK; Tedesco FS
    Nat Protoc; 2015 Jul; 10(7):941-58. PubMed ID: 26042384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myogenic induction of adult and pluripotent stem cells using recombinant proteins.
    Perini I; Elia I; Lo Nigro A; Ronzoni F; Berardi E; Grosemans H; Fukada S; Sampaolesi M
    Biochem Biophys Res Commun; 2015 Aug; 464(3):755-61. PubMed ID: 26164231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
    Mondragon-Gonzalez R; Perlingeiro RCR
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
    Féraud O; Valogne Y; Melkus MW; Zhang Y; Oudrhiri N; Haddad R; Daury A; Rocher C; Larbi A; Duquesnoy P; Divers D; Gobbo E; Brunet de la Grange P; Louache F; Bennaceur-Griscelli A; Mitjavila-Garcia MT
    PLoS One; 2016; 11(3):e0149291. PubMed ID: 26938212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells.
    Shelton M; Metz J; Liu J; Carpenedo RL; Demers SP; Stanford WL; Skerjanc IS
    Stem Cell Reports; 2014 Sep; 3(3):516-29. PubMed ID: 25241748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myogenic Differentiation of Mouse Embryonic Stem Cells That Lack a Functional Pax7 Gene.
    Czerwinska AM; Grabowska I; Archacka K; Bem J; Swierczek B; Helinska A; Streminska W; Fogtman A; Iwanicka-Nowicka R; Koblowska M; Ciemerych MA
    Stem Cells Dev; 2016 Feb; 25(4):285-300. PubMed ID: 26649785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. piggyBac Transposon Mediated Reprogramming and Flow Cytometry Analysis of CD44 and ICAM1 Cell-Surface Marker Changes.
    Brightwell S; Kaji K
    Methods Mol Biol; 2016; 1357():285-93. PubMed ID: 25410291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery.
    Sebe A; Ivics Z
    Methods Mol Biol; 2016; 1400():419-27. PubMed ID: 26895068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.